seen great progress over the last decades which led to some successful preliminary studies in humans [3,4] but is still not routinely implemented in the clinics, largely due to a shortage of donor organs. [5] Most trials in islet transplantation concentrated on injecting allogenic islets into the portal vein [6] and preventing rejection of donor islets with immunosuppressants. Since these tended to impair islet function [7,8] and in the liver islets are exposed to detrimental components in the blood, [5] soon thoughts turned to the possibility of protecting islets from the immune system by a thin coating of hydrogels. [9] Furthermore, protection from an immunological response might enable even xenotransplantation, for instance of porcine islets, [10] which could solve the problem of donor shortage.To achieve immune-isolating encapsulation, many researchers focused on alginate and alginate based hydrogel blends as coating, since this polymer cannot be digested in the human body lacking the relevant enzymes and has been shown to be nonimmunogenic if sufficiently purified. [11][12][13] Alginate is a polysaccharide extracted from brown algae, which can be crosslinked in different strengths by the addition of divalent cations such as Ca 2+ , Sr 2+ , or Ba 2+[14] and has been successfully used for encapsulation of different cell types in the past. [15] For pancreatic islets, either macro-or microencapsulation in alginate were established; in both cases islets have been found to retain their viability and functionality for a certain time, [16] but capsule size and composition definitely have an impact on function of islets, mainly as a function of diffusion distances. [17,18] Microcapsules only contain a single islet per capsule, encased in a thin layer of alginate, which decreases the distance between islets and the Transplantation of pancreatic islets is a promising strategy to alleviate the unstable blood-glucose control that some patients with diabetes type 1 exhibit and has seen many advances over the years. Protection of transplanted islets from the immune system can be accomplished by encapsulation within a hydrogel, the most investigated of which is alginate. In this study, islet encapsulation is combined with 3D extrusion bioprinting, an additive manufacturing method which enables the fabrication of 3D structures with a precise geometry to produce macroporous hydrogel constructs with embedded islets. Using a plottable hydrogel blend consisting of clinically approved ultrapure alginate and methylcellulose (Alg/MC) enables encapsulating pancreatic islets in macroporous 3D hydrogel constructs of defined geometry while retaining their viability, morphology, and functionality. Diffusion of glucose and insulin in the Alg/MC hydrogel is comparable to diffusion in plain alginate; the embedded islets continuously produce insulin and glucagon throughout the observation and still react to glucose stimulation albeit to a lesser degree than control islets.